A high expression of EGFR was associated with increased gene copy numbers, and non-small cell lung cancer patients given gefitinib were associated with significantly improved responses, lower progression rates and improved survival compared with tumors with low EGFR expression [26]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.